SG Americas Securities’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$59K Buy
52,602
+18,100
+52% +$20.3K ﹤0.01% 2411
2025
Q1
$27K Sell
34,502
-10,372
-23% -$8.12K ﹤0.01% 2936
2024
Q4
$74K Buy
44,874
+10,511
+31% +$17.3K ﹤0.01% 2515
2024
Q3
$120K Sell
34,363
-2,009
-6% -$7.02K ﹤0.01% 2596
2024
Q2
$119K Sell
36,372
-1,084
-3% -$3.55K ﹤0.01% 2146
2024
Q1
$275K Sell
37,456
-53,097
-59% -$390K ﹤0.01% 1553
2023
Q4
$339K Buy
90,553
+16,911
+23% +$63.3K ﹤0.01% 1559
2023
Q3
$156K Buy
+73,642
New +$156K ﹤0.01% 2244
2023
Q2
Sell
-11,000
Closed -$63K 2217
2023
Q1
$63K Buy
+11,000
New +$63K ﹤0.01% 2757
2022
Q3
Sell
-13,076
Closed -$324K 2886
2022
Q2
$324K Sell
13,076
-91,629
-88% -$2.27M ﹤0.01% 2125
2022
Q1
$4.06M Sell
104,705
-315,485
-75% -$12.2M 0.03% 438
2021
Q4
$24.6M Buy
420,190
+363,576
+642% +$21.3M 0.13% 90
2021
Q3
$3.36M Buy
56,614
+3,543
+7% +$210K 0.02% 738
2021
Q2
$4.61M Buy
53,071
+35,372
+200% +$3.07M 0.02% 579
2021
Q1
$1.46M Buy
17,699
+14,820
+515% +$1.22M 0.01% 1141
2020
Q4
$262K Sell
2,879
-74,392
-96% -$6.77M ﹤0.01% 2170
2020
Q3
$3.09M Buy
77,271
+72,860
+1,652% +$2.91M 0.02% 405
2020
Q2
$151K Sell
4,411
-21,024
-83% -$720K ﹤0.01% 2679
2020
Q1
$565K Buy
+25,435
New +$565K 0.01% 1427
2019
Q2
Sell
-9,637
Closed -$169K 2638
2019
Q1
$169K Buy
+9,637
New +$169K ﹤0.01% 2351
2017
Q4
Sell
-10,596
Closed -$42K 2672
2017
Q3
$42K Buy
+10,596
New +$42K ﹤0.01% 2864